AesPLLa 365mg
$138.69
Volume restoration | Reduction of wrinkles and folds | Neocollagenesis | Deep skin revitalization
L-Polylactic Acid (PLLA) | Medical Device
Application area: Face | Neck | Temples | Cheekbones
Privacy Policy
Shipping & delivery
Payment methods
AESPLLA 365mg (1 vial)
In the world of world-class aesthetic medicine, where conscious patients expect results that combine total safety with long-lasting efficacy, aesPlla sets new standards in three-dimensional facial reconstruction. This is not just another temporary filler – it is an innovative collagen stimulator that triggers a deep, biological synthesis of the skin's own collagen. For premium clinics, it is the foundation of modern anti-aging therapies. As a leading PLLA collagen stimulator distributor, Aesthetic Pharma has selected this product to provide doctors with a tool for creating harmonious, soft, and completely natural results. If you are analyzing the market and want to buy aesPlla online for clinics, our offer provides not only the best aesPlla wholesale price but also a full guarantee of originality and safety of a certified medical device. We are proud to be an aesPlla official supplier Europe.
MECHANISM OF ACTION – ADVANCED NEOCOLLAGENESIS
The effectiveness of aesPlla is based on intelligent, prolonged cellular stimulation, which allows for a gradual restoration of lost volume without an exaggerated effect. This mechanism is based on three pillars:
- Long-term stimulation of fibroblasts: Injected poly-L-lactic acid acts as a powerful inducer in the deep layers of the dermis, forcing a massive production of new type I and III collagen. This process successively rebuilds the facial structural framework. This makes it a highly sought-after poly-L-lactic acid dermal filler wholesale product.
- Spherical micro-crystallization (Next-generation technology): In professional debates concerning the aesPlla vs Sculptra comparison, it is the innovative, spherical structure of aesPlla particles that constitutes its greatest advantage. The uniform size of the microspheres minimizes the extrusion force required during injection and drastically reduces the risk of lump (nodule) or granuloma formation.
- Full biocompatibility and biodegradation: PLLA is a completely safe material, used in medicine for decades (e.g., in absorbable surgical sutures). Over time, it metabolizes into lactic acid and is naturally excreted from the body as water and carbon dioxide.
The preparation is dedicated to patients over 30 years of age who are beginning to experience lipoatrophy and thinning of the subcutaneous tissue. It provides a deep, velvety revitalization of cellular structures, restoring a noble, youthful contour to facial features.
INDICATIONS
- significant loss of facial volume (lipoatrophy, gravitational changes),
- deep nasolabial folds and marionette lines,
- sunken temples, tear trough, and cheekbone areas,
- disturbed facial oval and sagging jowls (laxity of the lower face),
- correction of post-operative asymmetries and atrophic acne scars.
COMPOSITION
Active ingredient: Poly-L-lactic acid (PLLA) – 150 mg
Excipients: Sodium carboxymethyl cellulose (CMC) 90 mg, Mannitol 125 mg
Total powder capacity: 365 mg
TREATMENT METHOD AND PROTOCOL
The safety and effectiveness of the therapy depend on the precision of administration. The official aesPlla injection protocol significantly streamlines the doctor's work thanks to optimized reconstitution time:
- Preparation: The powder should be dissolved in 5 ml of sterile water for injection. The full hydration process takes only about 3 hours, which is a huge improvement for clinics compared to older generation products.
- Administration: Injection into the deep layers of the dermis or subcutaneous tissue is recommended using a linear retrograde, cross-hatching (fanning) technique with a 26G cannula (after prior puncture with an 18G/21G needle).
- Post-treatment massage (The 5-5-5 Rule): A crucial element of success. The patient must massage the treated area for 5 minutes, 5 times a day, for 5 days after the procedure to ensure ideal distribution of the microspheres.
Standard therapy includes a series of 1 to 4 treatments at 4-week intervals. Regarding PLLA filler longevity and results, clinical studies indicate an impressive 2 to 3 years (even up to 36 months), making this product one of the best investments in youth for the patient.
PACKAGING
1 sterile vial containing 365 mg of powder for injectable suspension.
CONTRAINDICATIONS
- hypersensitivity to poly-lactic acid or excipients (CMC, mannitol),
- pregnancy and lactation,
- active infections, inflammation, or herpes at the planned injection site,
- tendency to form keloids and hypertrophic scars,
- active autoimmune diseases.
MANUFACTURER
Oreon Life Science – a globally recognized innovator in medical biotechnology. Creator of advanced anti-aging preparations, whose mission is to provide doctors with the safest biomaterials based on rigorous clinical trials and the highest quality certification.
Product for use only by professionals with appropriate qualifications. Aesthetic Pharma delivers exclusively authentic preparations directly from verified distribution channels, guaranteeing their originality and the highest biological purity.
Please read the package leaflet before use. Application to patients should be preceded by a thorough medical history.
The Key to Masterful Medical Practice
To achieve uncompromising safety and maximize results in premium patients, Aesthetic Pharma experts emphasize the importance of continuous medical education:
- Authorized competencies: Before introducing PLLA to your clinic, ensure you have completed dedicated PLLA biostimulator training courses. The correct technique for working with this specific polymer differs drastically from administering hyaluronic acid.
By choosing authorized solutions at Aesthetic Pharma, you invest in the authority of your clinic, the profitability of treatments, and the complete safety of your patients.
FREQUENTLY ASKED QUESTIONS (FAQ) – AESTHETIC PHARMA EXPERT ANSWERS
1. Analyzing medical debates regarding PLLA vs HA fillers – which preparation to choose for a patient with severe tissue loss?
From a clinical perspective, these are preparations with different purposes. Hyaluronic acid (HA) is a filler that provides an immediate but temporary volumetric effect. In the case of patients 35+ with general loss of tension, laxity, and lipoatrophy, poly-L-lactic acid (aesPlla) is the superior choice. It does not act as a volumetric "implant" but as a stimulator that forces the body to produce natural, native tissue. The effect after aesPlla builds up gradually but lasts three times longer than in the case of HA, without the risk of water retention (no "puffy face" effect).
2. Users are looking for a reliable source. Why is the choice of supplier so critical?
In the aesthetic medicine industry, the category of injectable products is the so-called YMYL (Your Money or Your Life) zone. This means the preparation must come from an uninterrupted cold chain and a verified source. As a professional distributor, Aesthetic Pharma ensures full transparency of production batches, long expiration dates, and a guarantee that the medicine/device has not degraded during transport. Purchasing from unknown sources is a direct threat to the patient's health.
3. Is the reconstitution of aesPlla still as time-consuming as with older poly-lactic acids?
Definitely not. Older generations of PLLA required up to 24-48 hours of advance preparation (hydration). Thanks to the advanced, microspherical architecture of the particles, aesPlla dissolves in just about 3 hours. This gives clinics unprecedented flexibility and allows for more efficient appointment calendar management, without the need to plan preparation a day in advance.
4. When will the patient notice the final results of the therapy?
AesPlla teaches patience but rewards it with naturalness. Immediately after the injection, the patient will notice filling resulting from the presence of sterile water and the carrier in the tissues – however, this swelling absorbs within a few days. True neocollagenesis begins 4 weeks after injection. Visible, satisfying firming and rebuilding of the facial framework become evident after about 8-12 weeks, and the full effect lasts continuously for up to 3 years, depending on the patient's genetics and lifestyle.
Specific References
Review
